Old Web
English
Sign In
Acemap
>
authorDetail
>
Indrajeet Singh
Indrajeet Singh
Amgen
Medicine
Pharmacology
Pharmacokinetics
Pharmacodynamics
Blinatumomab
5
Papers
32
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Blinatumomab Pharmacodynamics and Exposure–Response Relationships in Relapsed/Refractory Acute Lymphoblastic Leukemia
2018
The Journal of Clinical Pharmacology
Min Zhu
Andrea Kratzer
Jessica Johnson
Chris Holland
Christian Brandl
Indrajeet Singh
Andreas Wolf
Sameer Doshi
Show All
Source
Cite
Save
Citations (17)
A quantitative systems pharmacology (QSP) model to assess the action of blinatumomab in NHL patients (pts).
2016
Journal of Clinical Oncology
Theresa Yuraszeck
Derek W. Bartlett
Indrajeet Singh
Michael J. Reed
Sharan Pagano
Min Zhu
Show All
Source
Cite
Save
Citations (2)
A Phase I, First-in-Human Study of AMG 780, an Angiopoietin-1 and -2 Inhibitor, in Patients with Advanced Solid Tumors
2016
Clinical Cancer Research
Afshin Dowlati
Gordana Vlahovic
Ronald B. Natale
Erik Rasmussen
Indrajeet Singh
Yuying C. Hwang
John M. Rossi
Michael B. Bass
Gregory Friberg
Cheryl A. Pickett
Show All
Source
Cite
Save
Citations (7)
Pharmacokinetics/pharmacodynamics (PKPD) of blinatumomab in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia (r/r ALL).
2015
Journal of Clinical Oncology
Min Zhu
Andrea Kratzer
Jessica Johnson
Chris Holland
Christian Brandl
Indrajeet Singh
Andreas Wolf
Sameer Doshi
Show All
Source
Cite
Save
Citations (4)
A first-in-human study of AMG 780, an angiopoietin-1 and -2 (ANG1/2) inhibitor, in patients (pts) with advanced solid tumors.
2014
Journal of Clinical Oncology
Afshin Dowlati
Gordana Vlahovic
Ronald B. Natale
Erik Rasmussen
Indrajeet Singh
Yuying C. Hwang
John M. Rossi
Michael B. Bass
Gregory Friberg
Cheryl Ann Pickett-Gies
Show All
Source
Cite
Save
Citations (2)
1